Last reviewed · How we verify
NCT05855876
Reversal of Battle-Related Aging (ROBRA) in a Special Operations Forces Cohort
trial testing subanesthetic ketamine infusions and bilateral cervical sympathetic blocks in Post-Traumatic Stress Disorder in 20 participants. Status unknown.
5 April 2024
Quick facts
| Lead sponsor | Stella Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 5 July 2023 |
| Primary completion | 5 April 2024 |
| Estimated completion | 5 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- subanesthetic ketamine infusions and bilateral cervical sympathetic blocks
Conditions studied
- Post-Traumatic Stress Disorder — all drugs for Post-Traumatic Stress Disorder →
- Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
Sponsor
Stella Center
Who can join
Adults 40 to 60, any sex, with Post-Traumatic Stress Disorder or Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine measures of GrimAge clock in SOF members undergoing treatment for PTSD/TBI using CSB.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Janssen-Aguilar R, Meshkat S, Al-Shamali HF, Perivolaris A, et al · · 2025 · cited 2× · PMID 40879152 · DOI 10.5152/pcp.2025.241027
Verify or expand the search:
- PubMed search for NCT05855876
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06332209 — Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico · NA · recruiting
- NCT06117306 — MDMA-assisted Massed Prolonged Exposure for PTSD · Phase 3 · recruiting
- NCT06002633 — Approach-Avoidance and Alcohol Challenge Study in PTSD · NA · recruiting
- NCT05254405 — An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder · Phase 4 · recruiting
- NCT04152993 — Responsive Neurostimulation for Post-Traumatic Stress Disorder · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05855876 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stella Center
- Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05855876.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing